Medovex Corp. Class A Warrant
MDVXW
MDVXW was delisted on the 14th of November, 2017.
0 hedge funds and large institutions have $0 invested in Medovex Corp. Class A Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $5K → $0 (-$5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5K |
MDVXW Hedge Fund Activity: Q4 2017 in Review
0 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Class A Warrant (MDVXW) for Q4 2017, worth a combined $0 — down 100% from $5K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MDVXW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $5K sold.
- 0 institutional investors held Medovex Corp. Class A Warrant (MDVXW) as of Q4 2017, down from 2 in Q3 2017.
- Funds reported $0 of Medovex Corp. Class A Warrant stock for Q4 2017, down 100% quarter-over-quarter.
- 0 funds opened new Medovex Corp. Class A Warrant positions in Q4 2017 and 2 closed out, a net change of -2 holders.
- The largest Medovex Corp. Class A Warrant seller in Q4 2017 was Susquehanna International Group, an estimated $5K sold.
Based on aggregated 13F filings for Q4 2017.